Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace You Might Also Like On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma November 16, 2017 Anpac Bio-Medical Science Wins Global Precision Medicine Industry Award: 2017 'Most Promising Cancer Screening Company' July 17, 2017 Exelixis Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 27, 2017
Anpac Bio-Medical Science Wins Global Precision Medicine Industry Award: 2017 'Most Promising Cancer Screening Company' July 17, 2017
Exelixis Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update February 27, 2017
